Discover another way to help patients with your Spectra Optia device

Whether you’re enjoying the heat or chilling in the air conditioning, we hope your summer is off to a good start. This edition of Access Point is here to help, with insights on using the Spectra Optia^™ Apheresis System for bone marrow processing (BMP). This procedure allows you to collect valuable hematopoietic stem cells (HSCs) from a patient’s or donor’s bone marrow, giving you another way to support patient care. Also in this issue: Learn about our convenient new online Help Center and get a timeline for the upcoming COBE 2991 sunset.

Therapeutic Systems

How to use Spectra Optia for bone marrow processing

You may know the Spectria Optia Apheresis System best for its role in therapeutic apheresis. But it can also be used for collecting valuable HSCs from a patient’s or donor’s bone marrow. In this article, we provide an overview of the BMP procedure used to collect HSCs and reduce red blood cells in the product prior to infusion.

Keep reading >

New Help Center

Introducing expanded customer support

At Terumo Blood and Cell Technologies, we are dedicated to improving your customer experience and providing top-notch customer support. That is why we are excited to introduce our new online Help Center as an additional way for you to connect with us and conveniently find help when you need it.

Keep reading >

Your Questions, Answered

Dear Access Point,

I recently experienced clumping during a BMP procedure. Is there anything I can do to address this issue?

— Lori in Denver, CO

Dear Lori,

Platelet clumping or the formation of clots may occur during a BMP procedure if the bone marrow was inadequately anticoagulated with ACD-A. The ACD-A must be added, 10% by volume, to the bone marrow product prior to processing. For example, if you have 1 liter of bone marrow (BM) product, you will need to add 100 mL of ACD-A.

If platelet clumps are visible, verify that the appropriate amount of ACD-A was added to the BMP bag. If needed, additional ACD-A may be added to the Accessory Set to prevent issues with collection efficiency. Please note that if additional ACD-A is added, the BM volume and product hematocrit (Hct) will need to be recalculated and the information on the (BM) data screen will need to be updated to reflect the changes that have been made.

For detailed information on how to calculate the necessary volume of ACD-A to add to BM product, see your Spectra Optia Apheresis System Operator’s Manual.

If you have a specific question about the Spectra Optia system, let us know. We will feature a reader question in each Access Point edition. Be sure to tell us your first name, hometown, and state or province. Questions not featured will be answered directly via email.

Submit a question

Resource Spotlight

> Bone Marrow Processing Brochure

Gain more insights on performing a BMP procedure on the Spectra Optia device.

Did You Know?

The COBE 2991 sunset is starting

You may have heard that Terumo Blood and Cell Technologies is sunsetting the COBE^™ 2991 Cell Processor. We will continue to support the system with respect to equipment service, technical support, and disposable sets based on the following timeline:

All disposable set orders must be placed by September 30, 2028.
All ordered disposable sets will be shipped by March 31, 2029.
Final sunset date of the COBE 2991 system — i.e., the end of support for spare parts, repairs, service agreements, and technical service — will be March 31, 2031.

For more information and a handy reference of these timelines, we suggest downloading the COBE 2991 Cell Processor Sunset Letter.

Events

Live From Lakewood

Trima Accel^TM Automated Blood Collection System: Adjustments That Impact Platelet Targets | July 18, 2024
White Blood Cell Depletion Run Values Screen and Fluid Balance Data on Spectra Optia | September 12, 2024

Learn more and register to attend these live and interactive webinar sessions from our headquarters in Lakewood, Colorado. If you would like a specific topic covered in one of these webinars, please send us an email.

Cell Collections Successions Workshops

June 19 or 20, 2024 | Orlando, FL

Hosted by OneBlood

If you are interested in attending a future workshop, please send us an email.

Need Support?

You're on the front lines of care, and we're here to assist.

Contact us online or via 877.339.4228.

Access previous issues

Stay Up to Date

could help you make the most of your Spectra Optia and your relationship with

Terumo Blood and Cell Technologies to do even more for your patients.

Spectra Optia^™ and Trima Accel^™ are either registered trademarks or trademarks of Terumo BCT, Inc. in the United States and/or other countries. See TerumoBCT.com/trademarks for details.